Michael Schamroth, Director at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 4,499 shares at $39.36 ($177K) on 2014-11-24, disclosed to the SEC on 2014-11-25.
Open-market sale of $177k BSTC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BSTC | SELL | 2014-11-14 | $204K | — | Filing → |
| BSTC.PK | SELL | 2008-03-26 | $595K | — | Filing → |